| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Brege Laura is a Director at Pacira BioSciences, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 4 sells.
Estimated insider holdings value: $2.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2019 | MIRM Mirum Pharmaceuticals, Inc. | Director | Buy | 10,000 | $11.22 | $112,200.00 | New | |
| Jan 9, 2019 | ACAD Acadia Pharmaceuticals Inc | Director | Sale+OE | 10,000 | $20.00 | $200,041.00 | -100% | |
| Jan 2, 2018 | ACAD Acadia Pharmaceuticals Inc | Director | Sale+OE | 25,000 | $30.06 | $751,542.50 | -100% | |
| Jun 6, 2016 | PCRX Pacira Biosciences, Inc. | Director | Sell | 1,000 | $46.95 | $46,950.00 | -50.0% | |
| Feb 11, 2015 | ACAD Acadia Pharmaceuticals Inc | Director | Sale+OE | 10,000 | $33.63 | $336,349.00 | -100% |